UiPath Stock Gains A Lift From Earnings Beat And Higher Guidance

• UiPath recently reported second quarter revenue of US$410.26 million and net income of US$36.09 million, issued higher full year fiscal 2027 guidance, and confirmed several senior leadership changes across finance, legal, and the board.
• Alongside these results, UiPath highlighted large scale customer usage such as Banco Azteca’s more than 8,800 automated processes, underlining how automation deployments are expanding in size and complexity on its platform.
• With UiPath raising full year revenue guidance, the next step is to see how this update reshapes the existing investment narrative.

Scan beyond UiPath and spot other automation and AI beneficiaries by reviewing our curated set of 37 robotics and automation stocks that could be riding similar momentum in enterprise workflows.

UiPath Investment Narrative Recap

To own UiPath, you need to believe that enterprises will keep scaling from pilot automations to large, governed platforms that bundle AI agents, orchestration, and classic RPA. The latest quarter showed UiPath generating US$410.26 million in revenue and US$36.09 million in net income, with full year fiscal 2027 guidance raised. That update keeps the near term catalyst squarely on execution against higher revenue and ARR targets, as well as on completing the SaaS and cloud push. The biggest near term risk still sits in deal timing and customer budgets, where any renewed delays would flow quickly into ARR and margin pressure.

The most relevant update here is UiPath’s new guidance for fiscal 2027, which points to revenue of US$1.789 billion to US$1.794 billion and ARR of US$2.065 billion to US$2.070 billion. That range frames the next few quarters. It tightens the focus on whether the automation platform, including offerings like Maestro and agentic tools, can keep existing customers expanding despite FX headwinds, SaaS transition drag, and rising competition in AI orchestration. Analyst commentary around AI impact and valuation now matters less than simple delivery against that guidance path and the quality of recurring usage behind it.

Yet there is still a practical friction point in the UiPath story that could upset this trajectory if ...

Read the full UiPath narrative to see the case behind these numbers.

UiPath’s current analyst narrative points to revenues of about US$2.1b and earnings of US$287.5 million by 2029, based on assumed annual revenue growth of 8.1%. This would involve a move from earnings of US$327.4 million today to that lower profit level, which implies an earnings decline of roughly US$40 million over the period rather than an increase.

UiPath's forecasts show a fair value of $13.31 versus a $14.01 share price, implying a 5% downside to its current price that leaves little room for error.

Exploring Other Perspectives

One alternate view on UiPath focuses less on FX headwinds and more on competition risk in AI orchestration. The most optimistic analysts were modelling revenue of about US$2.2b and earnings of roughly US$532.8 million by 2029, far above consensus. Your takeaway is simple: opinions differ sharply. Use this quarter’s jump in profitability and the CFO transition as a prompt to compare those upside assumptions with more cautious scenarios.

Want a quick sense check on where others land on UiPath's value? Compare your view with 9 other fair value estimates for UiPath.

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider trusting your own analysis and judgment.

• A great starting point for your UiPath research is our analysis highlighting 4 key rewards that could impact your investment decision.
• See our latest analysis for UiPath. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate UiPath's overall financial health at a glance.

Looking for more UiPath style investment ideas?

If the UiPath story has sharpened your thinking about automation and AI, it can help to line it up against other companies with very different profiles. Use the Simply Wall St Screener to widen your watchlist and pressure test your thesis across a broader set of businesses.

• If capital protection sits high on your list, compare UiPath with a group of companies that score well on resilience by checking out 82 resilient stocks with low risk scores.
• If balance sheet strength matters most to you, set UiPath alongside businesses that carry less leverage and stronger funding profiles using the list of solid balance sheet and fundamentals (24 results).
• If you want ideas that are less picked over by the market, round out your research with a 17 high quality undiscovered gems that may not yet be widely followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com